Skip to main content
. 2021 Feb 1;7(1):8. doi: 10.3390/ncrna7010008

Figure 1.

Figure 1

Proposed approach toward discovering and evaluating circulating miRNA biomarker candidates for prognosing and diagnosing AD-associated cognitive decline.